Plasma levels of cortisol, progesterone, oestradiol-17 beta and prostaglandin F2 alpha metabolite after ACTH (Synacthen Depot) administration in ovariectomized gilts.
In order to elucidate the effect of stress on reproductive hormones, the present study was designed to investigate the effect of adrenocorticotropic hormone (ACTH) on the plasma levels of cortisol, progesterone, oestradiol-17 beta and prostaglandin F2 alpha metabolite in ovariectomized gilts. Ovariectomy and cannulation of the jugular vein were performed within 1 week of oestrous detection, under general anaesthesia. Approximately 1 week after surgery, two gilts were each administered ACTH (Synacthen Depot) intravenously, at a dose of 0.01 mg/kg body weight, and one gilt was given saline solution (5 ml). The reverse was performed on the following day. The administration of ACTH was followed by a concomitant elevation of cortisol, progesterone and prostaglandin F2 alpha metabolite but not of oestradiol-17 beta. Peak cortisol, progesterone and prostaglandin F2 alpha metabolite levels were reached at 80 +/- 10.0, 80 +/- 10.0 and 46.6 +/- 13.3 min after ACTH administration and the durations of the peaks were 181.8 +/- 19.8, 308.1 +/- 49.7 and 181.8 +/- 7.9 min, respectively. The total area under the curve for cortisol, progesterone and prostaglandin F2 alpha metabolite was significantly higher in the ACTH than in the control group. The present results indicate that during stress, cortisol, progesterone and prostaglandin F2 alpha levels are elevated while the level of oestradiol-17 beta is less affected. It can be concluded that the administration of ACTH to ovariectomized gilts, results in the elevation of cortisol, progesterone and prostaglandin F2 alpha metabolite but not of oestradiol-17 beta.
Mwanza
A M
AM
Department of Obstetrics and Gynaecology, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Madej
A
A
Kindahl
H
H
Lundeheim
N
N
Einarsson
S
S
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000502:physiology; D000818:Animals; D019540:Area Under Curve; D003692:Delayed-Action Preparations; D015237:Dinoprost / Q000031:analogs & derivatives / Q000097:blood; D004958:Estradiol / Q000097:blood; D004972:Estrus Detection; D005260:Female; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D010052:Ovariectomy / Q000662:veterinary; D011374:Progesterone / Q000097:blood; D011863:Radioimmunoassay / Q000662:veterinary; D013312:Stress, Physiological / Q000503:physiopathology / Q000662:veterinary*; D013552:Swine; D013553:Swine Diseases / Q000503:physiopathology*
D003692:Delayed-Action Preparations; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D011374:Progesterone; D004958:Estradiol; D000324:Adrenocorticotropic Hormone; D015237:Dinoprost; D006854:Hydrocortisone